88369 M/phmtrc alysishquant/semiq
Also known as: morphometric analysis in situ hybridization quantitative, ISH quantitative analysis
Morphometric and photometric analysis of in situ hybridization specimens with quantitative or semiquantitative scoring.
In Plain Language
measured genetic probe analysis; counted color testing
Clinical Context
Quantitative assessment of FISH or in situ hybridization results for gene amplification scoring, especially in breast cancer.
RVU Breakdown
| Work RVU | 0.68 |
| Total RVU | 0.68 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
With a work RVU of 0.68, this code ranks in the 53rd percentile among Pathology & Lab codes — 1.0x the median (0.68). The highest wRVU in this category is 2.78.
Specialties
Frequently Asked Questions
What is CPT code 88369?
CPT 88369 (M/phmtrc alysishquant/semiq) is a Pathology & Lab code. Morphometric and photometric analysis of in situ hybridization specimens with quantitative or semiquantitative scoring.
Who uses CPT code 88369?
CPT 88369 is used by Pathology, Oncology, Molecular Pathology. Quantitative assessment of FISH or in situ hybridization results for gene amplification scoring, especially in breast cancer.
When is CPT 88369 used?
Quantitative assessment of FISH or in situ hybridization results for gene amplification scoring, especially in breast cancer.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.